Scientific publications

Molecular biology of bladder cancer

Rosell Costa D [SP]Robles JE [SP], Berián Polo JM.
Departamento de Urología, Facultad de Medicina, Universidad de Navarra, Pamplona, España

Magazine: Archivos Españoles de Urología

Date: Jul 1, 1999

Urology [SP]

OBJECTIVE
To analyze the factors that influence tumor progression and response to therapy.

METHODS
The new prognostic factors involved in the progression of bladder tumors that have been described in the literature, such as tumor antigen expression, molecular growth factors, cell adhesion molecules, oncogenes, tumor suppressor genes and mechanisms of tumor angiogenesis, are reviewed.

RESULTS/CONCLUSIONS
The etiopathogenesis of bladder cancer remains unknown and treatment is based on the clinical stage of the disease. The new tumor markers will permit a more individualized prognosis and treatment can be instituted according to the biological characteristics of the tumor.

CITATION  Arch Esp Urol. 1999 Jul-Aug;52(6):693-705

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra